Fueling Collaboration at DCAT

Join KBI Biopharma in New York City for DCAT Week 2025!

DCAT Week 2025

Join KBI Biopharma in New York City for DCAT Week 2025!

We are delighted to announce our participation in DCAT Week 2025, and are looking forward to networking, sharing industry insights, and learning from fellow thought leaders. 

Dates: March 17-20, 2025
Location: New York City, NY

SCHEDULE A MEETING>>

Join us at the 97th Annual DCAT Dinner

The KBI Biopharma team is eager to attend the DCAT Annual Dinner again this year. This highly anticipated exclusive event features some of the most notable and interesting special guests and speakers from a variety of areas including science, politics, entertainment and sports.

Date: Thursday, March 20, 2025
Location: New York Hilton Midtown

LEARN MORE>>

Join us at the DCAT Annual Dinner

The KBI Biopharma team is eager to attend the DCAT Annual Dinner again this year. This highly anticipated exclusive event features some of the most notable and interesting special guests and speakers from a variety of areas including science, politics, entertainment and sports.

Date: Thursday, March 20, 2025
Location: New York Hilton Midtown

LEARN MORE>>

KBI Biopharma Team of Global Leaders and Experts: 

Tim Lowery

Chief Executive Officer

 

   

 

Sigma Mostafa

Chief Scientific Officer

 

   

 

Katie Edgar

Chief Business Officer

   

 

Andrew Setikas

Senior VP, Business Development 

   

 

Kasper Øland 

VP, Business Development - EU/APAC

   

 

Ryan Hutchinson

Senior Director, Business Development

   

 

 

 

 

 

 

 

Kasper Øland 

VP, Business Development - EU/APAC

   

 

Ryan Hutchinson

Senior Director, Business Development

   

 

 

Moments from Previous DCAT Events: 

 

About KBI Biopharma: 

KBI Biopharma is a leading global contract development and manufacturing organization (CDMO) providing fully integrated, accelerated drug development and biologics manufacturing services and expertise to life science companies. With each of our 500+ customer partners, we work closely to personalize and accelerate drug development programs. Built upon a foundation of world-class analytics capabilities and extensive scientific and technical expertise, we deliver robust process development and clinical and commercial cGMP manufacturing services for mammalian, microbial, and cell therapy programs. Recognized for quality manufacturing, we help clients advance drug candidates into the clinic and beyond. 

Learn more about KBI Biopharma >>

About the Event: